Rachel Johnson Schiebout’s Post

The Biden Administration is spearheading a comprehensive strategy for biotechnology innovation through the Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy. In a new article, Andrew Ahrendt, manufacturing lead at PCL Construction, delves into the key components of this strategy, the vital role of the National Bioeconomy Board, and the incredible potential of biotechnology to tackle global challenges such as climate change, U.S. public health, pharmaceutical advancements, food supply chains, and national security. Biotechnology is a game-changer, revolutionizing healthcare, agriculture, and bio-defense. This initiative aims to ensure the U.S. remains a global leader in biotech innovation. Discover more about the vision and the future of biotechnology in the full article: bit.ly/4bRwVPl

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics